SCHEMBL29818604

SCHEMBL29818604

CC(C)(O)c1ncc(Br)cc1C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 1/20 0.36
MAP3K12 Q12852 1/20 0.35
CYP11B1 P15538 2/20 0.34
CYP11B2 P19099 2/20 0.34
CFTR P13569 5/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP19A1 P11511 1/20 0.32
CYP2C9 P11712 1/20 0.32
PLA2G1B P04054 1/20 0.32
ATG4B Q9Y4P1 1/20 0.32
SLC22A12 Q96S37 1/20 0.32
AR P10275 1/20 0.32
RET P07949 1/20 0.31
ASPH Q12797 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
KDR P35968 1/20 0.30
RXRA P19793 1/20 0.30
GRIN1 Q05586 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25206544 1.00 SSTR4 (0.36) SSTR4MAP3K12CYP11B1CYP11B2CFTR
SCHEMBL2147947 0.79 HTT (0.33) CYP11B1CYP11B2HTTKMT2A
SCHEMBL3954740 0.78 SSTR4 (0.32) SSTR4CYP11B1CYP11B2CFTRPLA2G1B
SCHEMBL5254693 0.77 S1PR1 (0.36) HTTKMT2A
SCHEMBL25922382 0.77 SSTR4 (0.36) SSTR4
SCHEMBL24869542 0.76 MAP3K12 (0.39) MAP3K12CYP11B1CYP11B2CYP3A4CYP2D6
SCHEMBL25315336 0.75 SSTR4 (0.35) SSTR4CFTRPLA2G1BATG4BSLC22A12
SCHEMBL30507044 0.75 SSTR4 (0.35) SSTR4CFTRPLA2G1BATG4BSLC22A12
SCHEMBL25206015 0.74 PLAU (0.43) HTTKMT2A
SCHEMBL22140337 0.74 KMT2A (0.41) PLA2G1BATG4BRETHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4284804-A1 TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERS Schrödinger, Inc. (US) 2023-12-06 EP disclosed
CN-117120442-A Tricyclic compounds useful for treating cancer, autoimmune disorders, and inflammatory disorders 薛定谔公司 2023-11-24 CN disclosed
WO-2022164789-A9 TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISORDERS SCHRÖDINGER, INC. (US) 2023-05-25 WO disclosed
WO-2022164789-A1 TRICYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, AUTOIMMUNE AND INFLAMMATORY DISODERS SCHRÖDINGER, INC. (US) 2022-08-04 WO disclosed